Advanced search
Publication Cover
Journal of Drug Targeting Volume 29, 2021 - Issue 3
Submit an article Journal homepage
381
Views
20
CrossRef citations to date
0
Altmetric
Original Articles

Dual functional nanoparticles efficiently across the blood–brain barrier to combat glioblastoma via simultaneously inhibit the PI3K pathway and NKG2A axis

Zheng Jina Department of Neurosurgery, The First Hospital of Jilin University, Changchun, PR China
,
Lianhua Piaob Department of Physiology, College of Basic Medical Sciences, Jilin University, Changchun, PR China
,
Guangchao Suna Department of Neurosurgery, The First Hospital of Jilin University, Changchun, PR China
,
Chuanxiang Lva Department of Neurosurgery, The First Hospital of Jilin University, Changchun, PR China
,
Yi Jinga Department of Neurosurgery, The First Hospital of Jilin University, Changchun, PR China
&
Rihua Jina Department of Neurosurgery, The First Hospital of Jilin University, Changchun, PR ChinaCorrespondence[email protected]
Pages 323-335 | Received 28 Jul 2020, Accepted 17 Oct 2020, Published online: 16 Nov 2020

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Yajing Wang, Ziwei Ding, Shiqun Lv, Jie Liu, Jie Pan, Yingcong Yu, Jun Gao & Xianfeng Huang. (2023) Development of tLyP-1 functionalized nanoliposomes with tunable internal water phase for glioma targeting. Journal of Liposome Research 33:4, pages 353-367.
Read now
Yanning Bao & Weiyue Lu. (2023) Targeting cerebral diseases with enhanced delivery of therapeutic proteins across the blood-brain barrier. Expert Opinion on Drug Delivery 0:0, pages 1-18.
Read now

Articles from other publishers (18)

Ravi Raj Singh, Indranil Mondal, Taskeen Janjua, Amirali Popat & Ritu Kulshreshtha. (2024) Engineered smart materials for RNA based molecular therapy to treat Glioblastoma. Bioactive Materials 33, pages 396-423.
Crossref
Xinyan Qiu & Jinlan Chen. (2023) LSINCT5: A Novel lncRNA in Cancers. Current Medicinal Chemistry 30:39, pages 4409-4420.
Crossref
Yang Xing, Feroza Yasinjan, Mei Yang, Yajie Du, Huayue Geng, Minghua He, Yingtong Wang, Jicheng Sun, Wei Jiang, Ling Zhang, Baofeng Guo & Kelong Fan. (2023) A scientometric analysis and up-to-date review of nano-based drug delivery systems in glioblastoma treatment. Nano Today 52, pages 101961.
Crossref
Cláudia Martins & Bruno Sarmento. (2023) Multi‐ligand functionalized blood‐to‐tumor sequential targeting strategies in the field of glioblastoma nanomedicine. WIREs Nanomedicine and Nanobiotechnology 15:5.
Crossref
Jia Guo, Zheng Yao, Feiyu Zhang & Junzi Wu. (2023) Application of Polymer Materials in Targeting Glioma. Anti-Cancer Agents in Medicinal Chemistry 23:11, pages 1284-1297.
Crossref
Leonardo Delello Di Filippo, Suzana Gonçalves de Carvalho, Jonatas Lobato Duarte, Marcela Tavares Luiz, Jessyca Aparecida Paes Dutra, Geanne Aparecida de Paula, Marlus Chorilli & João Conde. (2023) A receptor-mediated landscape of druggable and targeted nanomaterials for gliomas. Materials Today Bio 20, pages 100671.
Crossref
Cláudia Martins, Marco Araújo, Alessio Malfanti, Catarina Pacheco, Stuart J. Smith, Bernard Ucakar, Ruman Rahman, Jonathan W. Aylott, Véronique Préat & Bruno Sarmento. (2023) Stimuli‐Responsive Multifunctional Nanomedicine for Enhanced Glioblastoma Chemotherapy Augments Multistage Blood‐to‐Brain Trafficking and Tumor Targeting. Small 19:22.
Crossref
Hallie Gaitsch, Andrew M. Hersh, Safwan Alomari & Betty M. Tyler. (2023) Dendrimer Technology in Glioma: Functional Design and Potential Applications. Cancers 15:4, pages 1075.
Crossref
Ju Hyun LeeDana V. ChapmanW. Mark Saltzman. (2023) Nanoparticle Targeting with Antibodies in the Central Nervous System. BME Frontiers 4.
Crossref
Ülo LangelÜlo Langel. 2023. CPP, Cell-Penetrating Peptides. CPP, Cell-Penetrating Peptides 469 541 .
Tania Hernández-Jiménez, Pedro Cruz-Nova, Alejandra Ancira-Cortez, Brenda Gibbens-Bandala, Nancy Lara-Almazán, Blanca Ocampo-García, Clara Santos-Cuevas, Enrique Morales-Avila & Guillermina Ferro-Flores. (2022) Toxicity Assessment of [177Lu]Lu−iFAP/iPSMA Nanoparticles Prepared under GMP-Compliant Radiopharmaceutical Processes. Nanomaterials 12:23, pages 4181.
Crossref
Qiuxia Tan, Shaojing Zhao, Ting Xu, Qin Wang, Minhuan Lan, Li Yan & Xianfeng Chen. (2022) Getting drugs to the brain: advances and prospects of organic nanoparticle delivery systems for assisting drugs to cross the blood–brain barrier. Journal of Materials Chemistry B 10:45, pages 9314-9333.
Crossref
Sofia Parrasia, Ildikò Szabò, Mario Zoratti & Lucia Biasutto. (2022) Peptides as Pharmacological Carriers to the Brain: Promises, Shortcomings and Challenges. Molecular Pharmaceutics 19:11, pages 3700-3729.
Crossref
Hengde Li, Shuai Zha, Haolan Li, Haitao Liu, Ka‐Leung Wong & Angelo H. All. (2022) Polymeric Dendrimers as Nanocarrier Vectors for Neurotheranostics. Small 18:45.
Crossref
Xingyue Li, Wenjing Ta, Ruochen Hua, Jihong Song & Wen Lu. (2022) A Review on Increasing the Targeting of PAMAM as Carriers in Glioma Therapy. Biomedicines 10:10, pages 2455.
Crossref
Ellen Poot, Ander Maguregui, Valerie G. Brunton, Dirk Sieger & Alison N. Hulme. (2022) Targeting glioblastoma through nano- and micro-particle-mediated immune modulation. Bioorganic & Medicinal Chemistry 72, pages 116913.
Crossref
Rakesh Kumar Sahoo, Tanisha Gupta, Sanya Batheja, Amit Kumar Goyal & Umesh Gupta. (2022) Surface Engineered Dendrimers: A Potential Nanocarrier for the Effective Management of Glioblastoma Multiforme. Current Drug Metabolism 23:9, pages 708-722.
Crossref
Rinie Bajracharya, Alayna C. Caruso, Laura J. Vella & Rebecca M. Nisbet. (2021) Current and Emerging Strategies for Enhancing Antibody Delivery to the Brain. Pharmaceutics 13:12, pages 2014.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.